Advised on and secured the ICT Regulatory Sandbox (Special Demonstration) approval for a cross-border Federated Learning platform between Seoul National University Hospital and Mayo Clinic
Provided strategic counsel on the data governance and consent frameworks for the National Integrated Bio-Big Data Project (BIKO)
Successfully represented 34 domestic pharmaceutical companies in landmark litigations regarding NDMA impurities in Valsartan products, prevailing in both the High Court and the Supreme Court
Defended pharmaceutical companies in Special Investigation Team (SIT) probes by the MFDS and criminal proceedings concerning GMP violations and Narcotics Control Act compliance
Conducted regulatory due diligence (LDD) for M&A and equity investments in biotech, EMR, and CRO sectors, identifying critical licensing risks
Global Research Data Privacy & AI Regulation
Advised on and secured the ICT Regulatory Sandbox (Special Demonstration) approval for a cross-border Federated Learning platform between Seoul National University Hospital and Mayo Clinic
Provided strategic counsel on the data governance and consent frameworks for the National Integrated Bio-Big Data Project (BIKO)
Advised the Korea Health Information Service (KHIS) on the amendment of national standards for bio-health data terminology and transmission (FHIR/HL7)
Conducted comprehensive legal assessments on utilizing health data for AI model training and RWE-based research for leading medical device and IVD companies
Spearheaded enterprise-wide data privacy compliance projects for global healthcare leaders including J&J, Kenvue, Roche Diagnostics, and Novo Nordisk
Managed cross-border data transfer issues and supported responses to National Assembly audits (Health and Welfare Committee) for genomics and digital diagnostic firms
Healthcare Regulatory & Crisis Management
Successfully represented 34 domestic pharmaceutical companies in landmark litigations regarding NDMA impurities in Valsartan products, prevailing in both the High Court and the Supreme Court
Defended pharmaceutical companies in Special Investigation Team (SIT) probes by the MFDS and criminal proceedings concerning GMP violations and Narcotics Control Act compliance
Directed enterprise-wide compliance audits and transparency reporting (Sunshine Act) for various multinational pharmaceutical entities
Defended major retail corporations in administrative actions involving labeling violations of imported foods and healthcare products
Advised global medical device companies on regulatory investigations related to grievance handling, adverse event reporting, and GCP compliance
Reviewed issues relating to cross-border data transfers for genomic analysis and digital in vitro diagnostics companies, and supported responses to National Assembly audits before the Health and Welfare Committee
Bio & Digital Product Commercialization Strategy
Formulated Go-To-Market (GTM) strategies for innovative digital and combination products, focusing on the linkage between regulatory approval and pricing/reimbursement (P&R)
Conducted regulatory due diligence (LDD) for M&A and equity investments in biotech, EMR, and CRO sectors, identifying critical licensing risks
Negotiated and structured complex Data Transfer Agreements (DTA) and Collaborative R&D Agreements between multinational healthcare firms and top-tier Korean hospitals
Advised on the regulatory architecture for establishing innovative healthcare and beauty complexes within major retail platforms